Targeting EphA2 with miR-124 mediates Erlotinib resistance in <i>K-RAS</i> mutated pancreatic cancer

Jing Du(Zhejiang Provincial People's Hospital)
Journal of Pharmacy and Pharmacology
January 3, 2019
Cited by 29


Related Papers